Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-047452

Chairman and CEO bought 1,250 shares at an average $1.61 ($2,013)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-08-17 Purchase +1,000 $1.62 $1,620 10,677,146 D
Niihara Yutaka Chairman and CEO 2020-08-18 Purchase +250 $1.57 $393 10,677,396 D
Open-market purchases · 1,250 sh · avg $1.61 · $2,013
Loading xslF345X03/doc4.xml…